| FDC Back to Cashflow Statement | 
FDC Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹318 Cr | ₹221 Cr | ₹155 Cr | ₹162 Cr | ₹207 Cr | 
What is the latest Cash Flow from Operating Activities ratio of FDC ?
| Year | Cash Flow from Operating Activities | 
|---|---|
| Mar2025 | ₹318 Cr | 
| Mar2024 | ₹221 Cr | 
| Mar2023 | ₹155 Cr | 
| Mar2022 | ₹162 Cr | 
| Mar2021 | ₹207 Cr | 
How is Cash Flow from Operating Activities of FDC Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹318 Cr | 43.85 | |
| Mar2024 | ₹221 Cr | 42.51 | |
| Mar2023 | ₹155 Cr | -4.17 | |
| Mar2022 | ₹162 Cr | -21.94 | |
| Mar2021 | ₹207 Cr | - | |
Compare Cash Flow from Operating Activities of peers of FDC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FDC | ₹7,500.2 Cr | 5% | 0.9% | -14.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹405,452.0 Cr | 0.2% | 7.1% | -7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,089.0 Cr | 1% | 16.8% | 12.7% | Stock Analytics | |
| CIPLA | ₹121,299.0 Cr | -2.7% | 3.5% | 6.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹120,456.0 Cr | 0.6% | 0.4% | 4.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,965.9 Cr | -6.4% | -2.7% | -3.9% | Stock Analytics | |
FDC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year | 
| FDC | 5% | 0.9% | -14.7% | 
| SENSEX | -0.3% | 4.5% | 5.7% | 
You may also like the below Video Courses
 
                     
                                     
                                     
                                    